| Silver State Hearing & Balance, Inc. | |
|
501 Hammill Ln, Reno, NV 89511-1004 | |
| (775) 682-4000 | |
| (775) 682-4003 |
| Full Name | Silver State Hearing & Balance, Inc. |
|---|---|
| Type | Facility |
| Speciality | Audiologist |
| Location | 501 Hammill Ln, Reno, Nevada |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1801095518 | NPI | - | NPPES |
| 0001282438 | Medicaid | NV |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 231H00000X | Audiologist | A 148 (Nevada) | Primary |
| Provider Name | Richard Johnson |
|---|---|
| Provider Type | Practitioner - Qualified Audiologist |
| Provider Identifiers | NPI Number: 1982707303 PECOS PAC ID: 4284729369 Enrollment ID: I20071004000246 |
News Archive
Chronic stress is being investigated in a new Alzheimer's Society funded research project as a risk factor for developing dementia.
Genmab A/S announced today that on March 23, 2010 Genentech, Inc. and Biogen Idec, Inc. filed a declaratory relief complaint at the US District Court, Southern District of California against Genmab's collaboration partner GlaxoSmithKline (GSK) for patent infringement under US patent No 7,682,612 based on GSK's manufacture, marketing and sale of Arzerra™ in the United States for the treatment of fludarabine and alemtuzumab refractory chronic lymphocytic leukemia (CLL).
While our efforts to combat COVID-19 remain at the forefront of our day-to-day activities, the U.S. Food and Drug Administration also continues its work on a number of important public health issues and, in particular, the opioid crisis.
Dartmouth researchers and their colleagues have built the first smartphone app that automatically reveals students' mental health, academic performance and behavioral trends. In other words, your smartphone knows your state of mind - even if you don't - and how that affects you.
› Verified 4 days ago
| Provider Name | Christine N Schellin |
|---|---|
| Provider Type | Practitioner - Qualified Audiologist |
| Provider Identifiers | NPI Number: 1427003425 PECOS PAC ID: 3476648569 Enrollment ID: I20071004000331 |
News Archive
Chronic stress is being investigated in a new Alzheimer's Society funded research project as a risk factor for developing dementia.
Genmab A/S announced today that on March 23, 2010 Genentech, Inc. and Biogen Idec, Inc. filed a declaratory relief complaint at the US District Court, Southern District of California against Genmab's collaboration partner GlaxoSmithKline (GSK) for patent infringement under US patent No 7,682,612 based on GSK's manufacture, marketing and sale of Arzerra™ in the United States for the treatment of fludarabine and alemtuzumab refractory chronic lymphocytic leukemia (CLL).
While our efforts to combat COVID-19 remain at the forefront of our day-to-day activities, the U.S. Food and Drug Administration also continues its work on a number of important public health issues and, in particular, the opioid crisis.
Dartmouth researchers and their colleagues have built the first smartphone app that automatically reveals students' mental health, academic performance and behavioral trends. In other words, your smartphone knows your state of mind - even if you don't - and how that affects you.
› Verified 4 days ago
| Provider Name | Nancy R Henderson |
|---|---|
| Provider Type | Practitioner - Qualified Audiologist |
| Provider Identifiers | NPI Number: 1558568246 PECOS PAC ID: 8224203443 Enrollment ID: I20111215000758 |
News Archive
Chronic stress is being investigated in a new Alzheimer's Society funded research project as a risk factor for developing dementia.
Genmab A/S announced today that on March 23, 2010 Genentech, Inc. and Biogen Idec, Inc. filed a declaratory relief complaint at the US District Court, Southern District of California against Genmab's collaboration partner GlaxoSmithKline (GSK) for patent infringement under US patent No 7,682,612 based on GSK's manufacture, marketing and sale of Arzerra™ in the United States for the treatment of fludarabine and alemtuzumab refractory chronic lymphocytic leukemia (CLL).
While our efforts to combat COVID-19 remain at the forefront of our day-to-day activities, the U.S. Food and Drug Administration also continues its work on a number of important public health issues and, in particular, the opioid crisis.
Dartmouth researchers and their colleagues have built the first smartphone app that automatically reveals students' mental health, academic performance and behavioral trends. In other words, your smartphone knows your state of mind - even if you don't - and how that affects you.
› Verified 4 days ago
| Provider Name | Michael A Hodes |
|---|---|
| Provider Type | Practitioner - Qualified Audiologist |
| Provider Identifiers | NPI Number: 1003066770 PECOS PAC ID: 4486803616 Enrollment ID: I20121004000044 |
News Archive
Chronic stress is being investigated in a new Alzheimer's Society funded research project as a risk factor for developing dementia.
Genmab A/S announced today that on March 23, 2010 Genentech, Inc. and Biogen Idec, Inc. filed a declaratory relief complaint at the US District Court, Southern District of California against Genmab's collaboration partner GlaxoSmithKline (GSK) for patent infringement under US patent No 7,682,612 based on GSK's manufacture, marketing and sale of Arzerra™ in the United States for the treatment of fludarabine and alemtuzumab refractory chronic lymphocytic leukemia (CLL).
While our efforts to combat COVID-19 remain at the forefront of our day-to-day activities, the U.S. Food and Drug Administration also continues its work on a number of important public health issues and, in particular, the opioid crisis.
Dartmouth researchers and their colleagues have built the first smartphone app that automatically reveals students' mental health, academic performance and behavioral trends. In other words, your smartphone knows your state of mind - even if you don't - and how that affects you.
› Verified 4 days ago
| Provider Name | Danielle Catherine Beebe |
|---|---|
| Provider Type | Practitioner - Qualified Audiologist |
| Provider Identifiers | NPI Number: 1457874539 PECOS PAC ID: 9032477542 Enrollment ID: I20171211000668 |
News Archive
Chronic stress is being investigated in a new Alzheimer's Society funded research project as a risk factor for developing dementia.
Genmab A/S announced today that on March 23, 2010 Genentech, Inc. and Biogen Idec, Inc. filed a declaratory relief complaint at the US District Court, Southern District of California against Genmab's collaboration partner GlaxoSmithKline (GSK) for patent infringement under US patent No 7,682,612 based on GSK's manufacture, marketing and sale of Arzerra™ in the United States for the treatment of fludarabine and alemtuzumab refractory chronic lymphocytic leukemia (CLL).
While our efforts to combat COVID-19 remain at the forefront of our day-to-day activities, the U.S. Food and Drug Administration also continues its work on a number of important public health issues and, in particular, the opioid crisis.
Dartmouth researchers and their colleagues have built the first smartphone app that automatically reveals students' mental health, academic performance and behavioral trends. In other words, your smartphone knows your state of mind - even if you don't - and how that affects you.
› Verified 4 days ago
| Provider Name | Allie Jordan Cope |
|---|---|
| Provider Type | Practitioner - Qualified Audiologist |
| Provider Identifiers | NPI Number: 1679241095 PECOS PAC ID: 2860841293 Enrollment ID: I20231211003572 |
News Archive
Chronic stress is being investigated in a new Alzheimer's Society funded research project as a risk factor for developing dementia.
Genmab A/S announced today that on March 23, 2010 Genentech, Inc. and Biogen Idec, Inc. filed a declaratory relief complaint at the US District Court, Southern District of California against Genmab's collaboration partner GlaxoSmithKline (GSK) for patent infringement under US patent No 7,682,612 based on GSK's manufacture, marketing and sale of Arzerra™ in the United States for the treatment of fludarabine and alemtuzumab refractory chronic lymphocytic leukemia (CLL).
While our efforts to combat COVID-19 remain at the forefront of our day-to-day activities, the U.S. Food and Drug Administration also continues its work on a number of important public health issues and, in particular, the opioid crisis.
Dartmouth researchers and their colleagues have built the first smartphone app that automatically reveals students' mental health, academic performance and behavioral trends. In other words, your smartphone knows your state of mind - even if you don't - and how that affects you.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Silver State Hearing & Balance, Inc. 501 Hammill Ln, Reno, NV 89511-1004 Ph: (775) 682-4000 | Silver State Hearing & Balance, Inc. 501 Hammill Ln, Reno, NV 89511-1004 Ph: (775) 682-4000 |
News Archive
Chronic stress is being investigated in a new Alzheimer's Society funded research project as a risk factor for developing dementia.
Genmab A/S announced today that on March 23, 2010 Genentech, Inc. and Biogen Idec, Inc. filed a declaratory relief complaint at the US District Court, Southern District of California against Genmab's collaboration partner GlaxoSmithKline (GSK) for patent infringement under US patent No 7,682,612 based on GSK's manufacture, marketing and sale of Arzerra™ in the United States for the treatment of fludarabine and alemtuzumab refractory chronic lymphocytic leukemia (CLL).
While our efforts to combat COVID-19 remain at the forefront of our day-to-day activities, the U.S. Food and Drug Administration also continues its work on a number of important public health issues and, in particular, the opioid crisis.
Dartmouth researchers and their colleagues have built the first smartphone app that automatically reveals students' mental health, academic performance and behavioral trends. In other words, your smartphone knows your state of mind - even if you don't - and how that affects you.
› Verified 4 days ago
Dr. Michael Anthony Hodes, AU.D. Audiologist Medicare: Accepting Medicare Assignments Practice Location: 501 Hammill Ln, Reno, NV 89511 Phone: 775-682-4000 Fax: 775-682-4003 | |
Dr. Kayla Kaikelii Navarro, Audiologist Medicare: Not Enrolled in Medicare Practice Location: 900 Ryland St, Reno, NV 89502 Phone: 775-329-7017 | |
Dr. Kasey O'hara, Audiologist Medicare: Not Enrolled in Medicare Practice Location: 2667 Enterprise Rd, Reno, NV 89512 Phone: 775-688-1341 Fax: 775-688-2984 | |
Dr. Angela Hayden, AUD, CCC-A Audiologist Medicare: Not Enrolled in Medicare Practice Location: 343 Elm St Ste 204, Reno, NV 89503 Phone: 775-329-7017 Fax: 775-323-0749 | |
Reno Hearing Center Audiologist Medicare: Medicare Enrolled Practice Location: 1855 Plumas St, Suite 5, Reno, NV 89509 Phone: 775-825-6006 Fax: 775-825-6188 | |
Dr. Chelsea Cathleen Peterson, AU.D. Audiologist Medicare: Medicare Enrolled Practice Location: 6630 S Mccarran Blvd Ste B16, Reno, NV 89509 Phone: 775-323-5566 | |
Khloe Layo Kaufman, AUD Audiologist Medicare: Accepting Medicare Assignments Practice Location: 900 Ryland St, Reno, NV 89502 Phone: 775-329-7017 Fax: 775-323-0749 |